Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2005
03/09/2005CN1192021C 3-azabicyclo [3.1.0] hexane derivatives as opiate receptors ligands
03/09/2005CN1192020C Antidiabetic agents
03/09/2005CN1192019C Cyclic amine derivatives
03/09/2005CN1192018C Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds
03/09/2005CN1192016C Process for preparation of 4-(des-dimethylamino)-tetracyclines
03/09/2005CN1192015C Cell adhesion inhibitors
03/09/2005CN1192011C Calcium receptor-active arylalkyl amines
03/09/2005CN1191865C Stabilization of lipid DNA formulations during nebulization
03/09/2005CN1191864C Hemoglobin-polysaccharide conjugates
03/09/2005CN1191861C Medicinal compositions containing anti-Fas antibody
03/09/2005CN1191859C Docetaxel in combination with rhumab HER2 monoclone antibody for treatment of cancers
03/09/2005CN1191857C potentiation of anti-CD38-immunotoxin cytotoxicity
03/09/2005CN1191854C Model membrane systems
03/09/2005CN1191850C Treatment of hemoatological malignancies associated with circulating tumor cells using chimeric anti -CD20 antibody
03/09/2005CN1191848C Chinese medicine prepn for treating throat and oral cavity diseases and its prepn process
03/09/2005CN1191844C Smelling treated Chinese medicine
03/09/2005CN1191838C Medicine powder in bag for curing rheumatism and osteoproliferation
03/09/2005CN1191836C Use of hydrogenous medicament active component in medical product preparation
03/09/2005CN1191835C Pharmaceutical use of pyrimidyl nucleoside
03/09/2005CN1191834C Aciclovir compositions contg. dimethicone
03/09/2005CN1191832C Neovascularization promoters
03/09/2005CN1191831C Compound Atenolol-Nifedipine slow releasing prepn
03/09/2005CN1191830C Orally disintegrating Nifedipine prepn and its recipe
03/09/2005CN1191829C Stable heptyl platinum solution preparation
03/09/2005CN1191828C Use of docosahexanoic acid and arachidonic acid enhancing growth of preterm infants
03/09/2005CN1191827C Tanrine derivatives usable in treatment of ophthamic disorders
03/09/2005CN1191826C Pharmaceutical formulation
03/09/2005CN1191825C Libaweilin slow-released preparation
03/09/2005CN1191824C Biconvex rapidly disintegrating dosage forms
03/08/2005US6864383 Ophthalmic compositions for treating ocular hypertension
03/08/2005US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents
03/08/2005US6864379 Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
03/08/2005US6864373 Stable amorphous celecoxib composite and process therefor
03/08/2005US6864368 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
03/08/2005US6864291 Agonists specific for the peripheral cannabinoid receptor
03/08/2005US6864290 Statine derivatives for the treatment of Alzheimer's disease
03/08/2005US6864288 Regulation of phospholipase D activity
03/08/2005US6864287 Cardiovascular disorders; hypotensive agents
03/08/2005US6864284 Ascorbic acid compounds, methods of synthesis and application use thereof
03/08/2005US6864283 Marine extracts; analogs of the spisulosine family
03/08/2005US6864282 9,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma
03/08/2005US6864280 Hypotensive agents; cardiovascular disorders
03/08/2005US6864279 2h-chromene derivatives metabolized both by cytochrome P450 and by a non-oxidative metabolic enzyme or system of enzymes; do not cause metabolic DDI when co-administered with other drugs
03/08/2005US6864277 Brain diosrders; cardiovascular disorders; central nervous system disorders; psychological disorders
03/08/2005US6864275 Anticancer agents; viricides
03/08/2005US6864274 Allantoin-containing skin cream
03/08/2005US6864273 Dyspepsia; gastrointestinal disorders; irritable bowel disorders
03/08/2005US6864272 Tetrazolium salts and derivatives, preferably tetrazolium red and tetrazolium violet, in combination with chemotherapeutic agents delivered in a polylactic acid carrier; noninvasive antitumor treatments
03/08/2005US6864270 Iron binding agents
03/08/2005US6864269 Concentrated, non-foaming solution of quarternary ammonium compounds and methods of use
03/08/2005US6864267 Calcilytic compounds
03/08/2005US6864266 4-piperidinyl alkyl amine derivatives as muscarinic receptor antagonists
03/08/2005US6864265 Chemokine receptor binding heterocyclic compounds
03/08/2005US6864264 1-adamantyl chalcones for the treatment of proliferative disorders
03/08/2005US6864263 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy
03/08/2005US6864262 Bladder disorders; incontinence; side effect reduction
03/08/2005US6864259 Antibacterial agents
03/08/2005US6864258 PH sensitivity; controlling blood concentration; cardiovascular disorders
03/08/2005US6864257 Usable as tranquillisers and hypnotics
03/08/2005US6864254 Kidney diosrders; brain disorders
03/08/2005US6864253 Heterocyclic amines such as 1-(3,4-methylenedioxyphenyl)-2-(5 -(3,4-dimethoxyphenyl)pyrimidin-2-yl)- 2,3,4,9-tetrahydro-1H-beta-carboline, used as enzyme inhibitors for prophylaxix of sexual disorders
03/08/2005US6864252 Treatment of cyclooxygenase mediated diseases, such as arthritis, neurodegeneration and colon cancer
03/08/2005US6864251 Treatment of LTB4-mediated inflammatory disorders with optically-pure (R)-2,3-benzodiazepines
03/08/2005US6864250 N-acylated lipophilic amino acid derivatives
03/08/2005US6864249 Pharmaceutical compositions containing them are of the class of thrombin inhibitors which are useful as anticoagulants.
03/08/2005US6864248 Androgenic steroid compounds and a method of making and using the same
03/08/2005US6864247 Therapeutic agents for glomerulosclerosis
03/08/2005US6864246 Anticholesterol agents
03/08/2005US6864244 Polymorphism crystal structure; stability
03/08/2005US6864243 Method for treating retinal degeneration with purinergic receptor agonists
03/08/2005US6864242 Mixtures of arginine, glutamine, proline and acyclic carboxy amines selected from leucine, isoleucine or valine, used as nutraceuticals for prophylaxis of metabolic disorders
03/08/2005US6864232 Agent for treating visual cell function disorder
03/08/2005US6864231 Glycoprotein matrix compositions and methods related thereto
03/08/2005US6864228 Use of bisphosphonates for the treatment of osteogenesis imperfecta
03/08/2005US6864094 Method of preserving oxygen infusions
03/08/2005US6864073 Avermectin aglycon synthase genes
03/08/2005US6864068 Mutant plant
03/08/2005US6864067 Compositions and methods for regulating bacterial pathogenesis
03/08/2005US6864064 18891, a novel human lipase
03/08/2005US6863914 Stable, aqueous dispersions and stable, water-dispersible dry powders of xanthophylls, and production and use of the same
03/08/2005US6863906 Two or more of the following compounds: S-adenosylmethionine, L-ergothioneine and a substance selected from Milk thistle (Silybum marianum), silymarin or active components of silymarin for the treatment of liver tissues
03/08/2005US6863904 Compositions and methods for prophylactic and therapeutic supplementation of nutrition in subjects
03/08/2005US6863902 Mixture of methyl hydrogen 9,11 alpha-epoxy-17 alpha-hydroxy-3-oxopregn-4-ene-7-alpha, 21-dicarboxylate, gamma-lactone and carriers administered as aldosterone receptor antagonists, for prophylaxis of cardiovascular disorders
03/08/2005US6863898 Method and composition for treating hairy hoof warts
03/08/2005US6863885 Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
03/08/2005US6863865 Sterilization of pharmaceuticals
03/08/2005US6863693 Phospholipid-coated implants
03/08/2005US6863647 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
03/08/2005US6862890 Process for production of nanoparticles and microparticles by spray freezing into liquid
03/08/2005CA2446562C Pharmaceutical formulation of fluticasone propionate
03/08/2005CA2351848C Method for increasing pet activity
03/08/2005CA2318125C Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate
03/08/2005CA2290482C Fructan containing composition for the prevention and treatment of colon cancer
03/08/2005CA2262776C Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase
03/08/2005CA2190134C Continuous method of grinding pharmaceutical substances
03/08/2005CA2162716C Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins, its preparation and use
03/08/2005CA2120743C Antiviral acyclic phosphonomethoxyalkyl substituted, alkenyl and alkynyl purine and pyrimidine derivatives
03/03/2005WO2005019440A1 Methods for enhancing embryo viability
03/03/2005WO2005019434A2 Serine protease inhibitors for treatment of bacterial infections
03/03/2005WO2005019240A2 Melanin concentrating hormone receptor antagonists
1 ... 4764 4765 4766 4767 4768 4769 4770 4771 4772 4773 4774 4775 4776 4777 4778 4779 4780 4781 4782 4783 4784 ... 7860